Random

psychopharmacology

Featured Neuroscience Open Neuroscience Articles Psychology

·June 9, 2020·3 min read

Antioxidants in brain linked to improved psychosis treatment

Patients with psychosis who have higher levels of an antioxidant called glutathione responded more quickly to medications and had improved outcomes. Researchers estimate a 10% increase in antioxidants could lead to reduced time spent in hospital for those with psychosis.

Featured Neuroscience Open Neuroscience Articles Psychology

·July 11, 2022·5 min read

Study Determines Psychedelic Mushroom Microdoses Can Improve Mood and Mental Health

Study reveals those who microdosed psilocybin for 30 days showed greater improvements in mood, mental health, and psychomotor abilities than those who did not microdose. The findings have positive implications for the use of psychedelics to help treat mental health disorders.

Featured Neurology Psychology

·December 14, 2020·4 min read

Schizophrenia May Be Similar to Immune Disorders

Schizophrenia may, in part, be caused by immune system dysfunction, a new study reports. Treatment with Methotrexate, a drug commonly prescribed for autoimmune disorders like R.A, produced positive effects against some prominent schizophrenia symptoms.

Featured Neuroscience Psychology

·December 30, 2022·4 min read

Ketamine Found to Increase Brain Noise

By inhibiting NMDA receptors, ketamine increases noise to gamma frequencies in one layer of the thalamic nucleus and one lay of the somatosensory cortex. Findings suggest psychosis may be triggered by an increase in background noise impairing thalamocortical neurons which may be caused by a malfunction in NMDA receptors affecting the balance of inhibition and excitation in the brain.

Featured Neuroscience Psychology

·September 22, 2022·6 min read

Adults With a History of Childhood Trauma Can Benefit From Recommended Depression Treatments, Contrary to Current Theory

Patients with major depressive disorder who experienced trauma during childhood see symptom improvement following psychopharmacological intervention, psychotherapy, or a combination of both.

Featured Neuroscience Psychology

·October 12, 2016·4 min read

Antidepressants During Pregnancy Associated with Childhood Language Disorders

Researchers report a 37 percent increase in speech or language disorders in the offspring of mothers who used SSRI antidepressants while pregnant.

This shows two mice and a stick and ball chemical structure

Featured Neuroscience Psychology

·May 25, 2021·4 min read

Non-Hallucinogenic Psychedelic Analog Reverses Effects of Stress in Mice

A single dose of tabernanthalog (TBG), a non-hallucinogenic psychedelic analog, corrects stress-induced behavioral deficits, including anxiety and cognitive inflexibility, in mouse models. Additionally, the compound promoted neurogenesis and restores neural circuits in brain areas damaged by stress.

This shows a swirly outline of a person painted blue

Featured Neuroscience Neuroscience Videos Psychology

·March 19, 2022·4 min read

AI Maps Psychedelic ‘Trip’ Experiences to Regions of the Brain, Opening New Route to Psychiatric Treatments

AI technology helped map out diverse and subjective psychedelic experiences to different brain regions.

Featured Neuroscience Psychology

·February 17, 2022·5 min read

Study of LSD Microdosing Doesn’t Show a Therapeutic Effect

Researchers say they have found no evidence LSD microdosing improves mood or cognitive function.

Featured Genetics Neuroscience Psychology

·July 27, 2022·3 min read

The Role of Genetic Variants on Psychedelics’ Therapeutic Effects

Genetic variants of the 5-HT2A serotonin receptor may explain why some respond to psychedelic therapies for the treatment of mental health disorders while others don't.

Featured Neuroscience Psychology

·December 11, 2019·7 min read

Rave new world: Scientists pry apart party drug’s therapeutic, addictive qualities

Researchers have distinguished two different molecular pathways responsible for addiction and the prosocial feelings generated by MDMA. The findings could lead to novel treatments for psychiatric disorders marked by withdrawal and social awkwardness.

This shows psychedelic swirls around a person's head

Featured Neuroscience Psychology

·January 17, 2020·2 min read

Psychedelic drugs could help treat PTSD

Backing up previous research, a new study reveals psychedelics can have beneficial effects for treating PTSD when combined with traditional trauma-focused psychotherapy. Findings suggest MDMA assisted therapy is significantly more effective at treating patients with persistent PTSD than psychotherapy alone.

1 2 3 … 32

psychopharmacology

Antioxidants in brain linked to improved psychosis treatment

Study Determines Psychedelic Mushroom Microdoses Can Improve Mood and Mental Health

Schizophrenia May Be Similar to Immune Disorders

Ketamine Found to Increase Brain Noise

Adults With a History of Childhood Trauma Can Benefit From Recommended Depression Treatments, Contrary to Current Theory

Antidepressants During Pregnancy Associated with Childhood Language Disorders

Non-Hallucinogenic Psychedelic Analog Reverses Effects of Stress in Mice

AI Maps Psychedelic ‘Trip’ Experiences to Regions of the Brain, Opening New Route to Psychiatric Treatments

Study of LSD Microdosing Doesn’t Show a Therapeutic Effect

The Role of Genetic Variants on Psychedelics’ Therapeutic Effects

Rave new world: Scientists pry apart party drug’s therapeutic, addictive qualities

Psychedelic drugs could help treat PTSD

Predicting PTSD: Brain Scans Unravel Trauma’s Long-term Effects

Brain’s Molecular Response to Psychological Loss

Brain’s Dual-Chemical Switch for Attention Revealed

Subscribe